Axcan Pharma to present at the UBS Global Specialty Pharmaceuticals Conference

TSX SYMBOL (Toronto Stock Exchange):        AXP
NASDAQ SYMBOL (NASDAQ National Market):    AXCA

MONT SAINT-HILAIRE, April 18 /CNW Telbec/ - Axcan Pharma Inc. ("Axcan" or
the "Company") today announced that on Tuesday, April 25th, 2006, President
and Chief Executive Officer, Frank A.G.M. Verwiel, M.D., will present an
overview of the Company at the UBS Global Specialty Pharmaceuticals Conference
to be held in New York, NY. This presentation will take place at 1:30 p.m.
(Eastern time).
A live webcast of Axcan's presentation will also be accessible via the
Company's website at www.axcan.com.

Axcan is a leading specialty pharmaceutical company involved in the field
of gastroenterology. The Company markets a broad line of prescription products
sold for the treatment of symptoms in a number of gastrointestinal diseases
and disorders such as inflammatory bowel disease, irritable bowel syndrome,
cholestatic liver diseases and complications related to cystic fibrosis.
Axcan's products are marketed by its own sales force in North America and
Europe. Its common shares are listed on the Toronto Stock Exchange under the
symbol "AXP" and on the NASDAQ National Market under the symbol "AXCA".